Vinpocetine Tablets
Developed to mitigate cerebral circulation deficits to support cognitive functions and alleviate neuronal vascular stress.
- Category
- Neurology
- Active ingredient
- Vinpocetine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 5mg
The exact manufacturer offered is confirmed by the fulfilment partner before supply.
Prescription and consultation requirements for Vinpocetine Tablets vary by destination and are determined by the fulfilment partner.
Vinpocetine Tablets details
- Conditions
- Cerebrovascular Disease · Cognitive Impairment
- Alternative names
- cavinton
- Therapeutic class
- Phosphodiesterase Inhibitor
- Pharmacological class
- Cerebral Vasodilator
- Known off-label uses
- tinnitus; meniere's disease
- Contraindications
- acute cerebral haemorrhage; severe ischaemic heart disease; pregnancy
- Minor side effects
- headache; dizziness; nausea
- Moderate side effects
- insomnia; flushing; dry mouth
- Serious side effects
- severe hypotension, requires immediate medical attention
- Dosage forms
- Tablet
- Administration route
- Oral use
- Onset Time
- 2–4 weeks
- Duration
- 12 hours
- Storage instructions
- Store below 25°C. Keep dry.
- Drug interactions
- Warfarin; Aspirin
- Age restrictions
- Approved for adults.
- Pregnancy and breastfeeding
- TGA Category D: High risk of fetal toxicity. Do not use. Breastfeeding: Avoid.
Patient summary
developed to mitigate cerebral circulation deficits to support cognitive functions and alleviate neuronal vascular stress.
Mechanism of action
Blocks phosphodiesterase, raising intracellular cyclic GMP to promote vasodilation and enhance microvascular oxygenation in the brain.
What you will receive
Vinpocetine Tablets is a generic medicine sold under the name of its active ingredient, Vinpocetine, rather than under a brand.
- The fulfilment partner confirms the offered manufacturer and product before supply.
- Check the active ingredient, strength, form and pack shown at checkout before confirming an order.